Friday, December 18, 2009, 8:43pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Javelin Pharmaceuticals, Inc. (JAV)

 At 16:01 EST: 1.30 USD  Up 0.07 (5.69%)  
MORE ON JAV
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
JAVELIN PHARMACEUTIC (AMEX:JAV) Delayed quote dataEdit
After Hours: 1.34 Up 0.04 (3.08%) as of 6:41pm EST on 12/18/09
Last Trade: 1.30 USD
Trade Time: 4:01PM EST
Change: Up 0.07 (5.69%)
Prev Close: 1.23
Open: 1.37
Bid: N/A
Ask: N/A
1y Target Est: 3.17
Day's Range: 1.28 - 1.40
52wk Range: 0.91 - 2.28
Volume: 9,838,878
Avg Vol (3m): 488,228
Market Cap: 83.02M
P/E (ttm): N/A
EPS (ttm): -0.72
Div & Yield: N/A (N/A%)
Javelin Pharmaceuticals, Inc. (JAV)
1d  5d  3m  6m  1y  2y  5y 
Free Annual Reports
 Add JAV to Portfolio   Download Data

HEADLINES
• JAVELIN PHARMACEUTICALS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Fri 5:31pm)
• Javelin to merge with Myriad Pharma
at bizjournals.com (Fri 2:05pm)
• UPDATE - Myriad Pharma to buy Javelin Pharma for $96 mln
at Reuters (Fri 11:31am)
• SenoRx, Javelin: Early Volume Plays
at TheStreet.com (Fri 9:28am)
• Myriad buying Javelin in stock deal
AP (Fri 8:58am)
• Myriad Pharma to merge with Javelin
at MarketWatch (Fri 8:33am)
• InPlay: Javelin Pharmaceutic to be acquired by Myriad Pharmaceuticals (MYRX)
Briefing.com (Fri 8:17am)
• Javelin Pharma submits drug candidate to FDA
at bizjournals.com (Wed, Dec 2)
• Javelin Pharmaceuticals Submits Dyloject New Drug Application to FDA for Management of Acute Moderate-to-Severe Pain in Adults
Business Wire (Wed, Dec 2)
• JAVELIN PHARMACEUTICALS, INC Financials
EDGAR Online Financials (Fri, Nov 13)
More Headlines for JAV...
ANALYST
EPS Est (next year) (Dec-09) : -0.58
EPS Est (in 2 years) (Dec-10) : -0.37
Avg Rec (current)*: 1.0
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices